PMC:7341831 / 2249-2860 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":132,"end":137},"obj":"Body_part"},{"id":"T5","span":{"begin":494,"end":498},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":132,"end":137},"obj":"Body_part"},{"id":"T4","span":{"begin":494,"end":498},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PubTator","denotations":[{"id":"88","span":{"begin":142,"end":150},"obj":"Species"},{"id":"89","span":{"begin":359,"end":367},"obj":"Species"},{"id":"90","span":{"begin":39,"end":50},"obj":"Species"},{"id":"91","span":{"begin":91,"end":93},"obj":"Chemical"},{"id":"92","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"93","span":{"begin":373,"end":381},"obj":"Disease"}],"attributes":[{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"Tax:9606"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"Tax:9606"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"Tax:746128"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"MESH:C012990"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"MESH:C000657245"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T35","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"T36","span":{"begin":373,"end":381},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T11","span":{"begin":132,"end":137},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T12","span":{"begin":132,"end":137},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T13","span":{"begin":341,"end":342},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":494,"end":498},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T15","span":{"begin":494,"end":498},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T16","span":{"begin":538,"end":539},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T17","span":{"begin":600,"end":601},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25","span":{"begin":91,"end":93},"obj":"Chemical"},{"id":"T27","span":{"begin":540,"end":544},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A26","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_29287"},{"id":"A28","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_30050"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":76,"end":86},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T4","span":{"begin":91,"end":93},"obj":"GlycoEpitope"}],"attributes":[{"id":"A4","pred":"glyco_epitope_db_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":0,"end":320},"obj":"Sentence"},{"id":"T26","span":{"begin":321,"end":493},"obj":"Sentence"},{"id":"T27","span":{"begin":494,"end":611},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"2_test","denotations":[{"id":"32638890-29325970-134289066","span":{"begin":311,"end":312},"obj":"29325970"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T38","span":{"begin":39,"end":50},"obj":"NCBITaxon:5052"},{"id":"T39","span":{"begin":64,"end":75},"obj":"UBERON:0001004"},{"id":"T40","span":{"begin":132,"end":137},"obj":"UBERON:0000178"},{"id":"T41","span":{"begin":156,"end":164},"obj":"SP_7"},{"id":"T42","span":{"begin":182,"end":191},"obj":"UBERON:0007221"},{"id":"T43","span":{"begin":373,"end":381},"obj":"SP_7"},{"id":"T44","span":{"begin":494,"end":498},"obj":"UBERON:0002048"},{"id":"T74035","span":{"begin":39,"end":50},"obj":"NCBITaxon:5052"},{"id":"T644","span":{"begin":64,"end":75},"obj":"UBERON:0001004"},{"id":"T47982","span":{"begin":132,"end":137},"obj":"UBERON:0000178"},{"id":"T97836","span":{"begin":156,"end":164},"obj":"SP_7"},{"id":"T31476","span":{"begin":182,"end":191},"obj":"UBERON:0007221"},{"id":"T4469","span":{"begin":373,"end":381},"obj":"SP_7"},{"id":"T35848","span":{"begin":494,"end":498},"obj":"UBERON:0002048"}],"text":"Therefore, testing for the presence of Aspergillus spp in lower respiratory secretions and GM (not routinely positive in peripheral blood) in patients with COVID-19 in the intensive care unit (ICU) should be considered to allow timely treatment and avoid potential immunosuppression with the use of medications 5 , 6 . However, conducting a bronchoscopy in patients with COVID-19 is relatively contraindicated due to the biological risk and clinical deterioration caused by the procedure 9 . Lung biopsy, which might also be considered a gold standard diagnosis method, is also impractical in such a scenario."}